Open Research Newcastle
Browse

Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ.

Download (1.14 MB)
journal contribution
posted on 2025-05-09, 01:06 authored by Sebastian A. Stifter, Antony Y. Matthews, Niamh E. Mangan, Ka Yee Fung, Alexander Drew, Michelle D. Tate, Tatiana P. Soares da Costa, Daniel Hampsey, Jemma MayallJemma Mayall, Philip Hansbro, Albert Garcia Minambres, Sahar G. Eid, Johnson Mak, Judy Scoble, George Lovrecz, Nicole A. deWeerd, Paul J. Hertzog
The type I interferons (IFNs) are a family of cytokines with diverse biological activities, including antiviral, antiproliferative, and immunoregulatory functions. The discovery of the hormonally regulated, constitutively expressed IFNϵ has suggested a function for IFNs in reproductive tract homeostasis and protection from infections, but its intrinsic activities are untested. We report here the expression, purification, and functional characterization of murine IFNϵ (mIFNϵ). Recombinant mIFNϵ (rmIFNϵ) exhibited an α-helical fold characteristic of type I IFNs and bound to IFNα/β receptor 1 (IFNAR1) and IFNAR2, but, unusually, it had a preference for IFNAR1. Nevertheless, rmIFNϵ induced typical type I IFN signaling activity, including STAT1 phosphorylation and activation of canonical type I IFN signaling reporters, demonstrating that it uses the JAK–STAT signaling pathway. We also found that rmIFNϵ induces the activation of T, B, and NK cells and exhibits antiviral, antiproliferative, and antibacterial activities typical of type I IFNs, albeit with 100–1000-fold reduced potency compared with rmIFNα1 and rmIFNβ. Surprisingly, although the type I IFNs generally do not display cross-species activities, rmIFNϵ exhibited high antiviral activity on human cells, suppressing HIV replication and inducing the expression of known HIV restriction factors in human lymphocytes. Our findings define the intrinsic properties of murine IFNϵ, indicating that it distinctly interacts with IFNAR and elicits pathogen-suppressing activity with a potency enabling host defense but with limited toxicity, appropriate for a protein expressed constitutively in a sensitive mucosal site, such as the reproductive tract.

Funding

NHMRC

1003591

1059242

History

Journal title

Journal of Biological Chemistry

Volume

293

Issue

9

Pagination

3168-3179

Publisher

American Society for Biochemistry and Molecular Biology

Language

  • en, English

College/Research Centre

Faculty of Health and Medicine

School

School of Biomedical Sciences and Pharmacy

Rights statement

© 2018 by The American Society for Biochemistry and Molecular Biology, Inc. This is an open access article under the CC BY license. (https://creativecommons.org/licenses/by/4.0/).

Usage metrics

    Publications

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC